Oruka Therapeutics Management
Management criteria checks 0/4
Oruka Therapeutics' CEO is Lawrence Klein, appointed in Feb 2024, has a tenure of less than a year. directly owns 5.07% of the company’s shares, worth €40.09M. The average tenure of the management team and the board of directors is 0.5 years and 0.6 years respectively.
Key information
Lawrence Klein
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 5.1% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Lawrence Klein (42 yo)
less than a year
Tenure
Dr. Lawrence Otto Klein, Ph D., served as Partner of Versant Venture Management, LLC since joining from 2023 to February 2024. He served as an Independent Director at Dyne Therapeutics, Inc. since Septembe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | 5.07% € 40.1m | |
| Senior Vice President of Finance & Treasurer | less than a year | no data | no data | |
| Senior Vice President of Operations & Boston Site Head | no data | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| General Counsel & Secretary | less than a year | no data | no data | |
| Vice President of Corporate Development & Strategy | no data | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| VP and Head of Chemistry | no data | no data | no data | |
| Senior Vice President of Nonclinical Research & Development | no data | no data | no data |
0.5yrs
Average Tenure
49yo
Average Age
Experienced Management: HQ1's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | 5.07% € 40.1m | |
| Independent Director | less than a year | no data | no data | |
| Independent Chairman of Board | less than a year | no data | no data | |
| Independent Director | less than a year | no data | 0.51% € 4.0m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data |
0.6yrs
Average Tenure
40.5yo
Average Age
Experienced Board: HQ1's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.